Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × NIH × Pneumonia × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 71 Carcinoma, Non-Small-Cell Lung 38 Lung Neoplasms 36 Colonic Neoplasms 34 Leukemia 32 Rectal Neoplasms 30 Lymphoma 30 Colorectal Neoplasms 29 Prostatic Neoplasms 23 Multiple Myeloma 23 Lymphoma, Follicular 19 Ovarian Neoplasms 18 Lymphoma, Non-Hodgkin 17 Leukemia, Myeloid, Acute 17 Lymphoma, Large B-Cell, Diffuse 16 Melanoma 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Neoplasms, Plasma Cell 14 Urinary Bladder Neoplasms 13 Lymphoma, Large-Cell, Immunoblastic 13 Head and Neck Neoplasms 13 Burkitt Lymphoma 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Carcinoma, Ovarian Epithelial 12 Pancreatic Neoplasms 11 Myelodysplastic Syndromes 11 Leukemia, Myelomonocytic, Acute 11 Leukemia, Monocytic, Acute 11 Leukemia, Megakaryoblastic, Acute 11 Leukemia, Erythroblastic, Acute 11

Interventions

Methylprednisolone 1 Etanercept 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

37 enrolled 20 charts

Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡